---
title: "Omega Diagnostics Gp (ODX.L) Update on progress of UK-Rapid Test Consortium"
publisher: "Share Talk"
author: "sharetalk"
published: "2020-06-03T10:27:27+00:00"
modified: "2020-06-03T10:27:27+00:00"
date: 2020-06-03
canonical: "https://www.share-talk.com/omega-diagnostics-gp-odx-l-update-on-progress-of-uk-rapid-test-consortium/"
category: "Healthcare"
categories: ["Healthcare"]
tags: ["allergy testing", "antibody test", "Colin King", "COVID-19", "Memorandum of Understanding", "ODX", "Omega Diagnostics Gp", "Rapid Test", "University of Oxford"]
image: "https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1"
format: "news"
language: "en-GB"
---

# Omega Diagnostics Gp (ODX.L) Update on progress of UK-Rapid Test Consortium

**Published:** June 3, 2020
**Author:** sharetalk
**Categories:** Healthcare
**Tags:** allergy testing, antibody test, Colin King, COVID-19, Memorandum of Understanding, ODX, Omega Diagnostics Gp, Rapid Test, University of Oxford
**Featured image:** ![](https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1)

---

**Significant progress in development with design freeze expected in June**

**Omega (AIM: ODX)**, the medical diagnostics company focused on CD4, food intolerance and allergy testing, notes the Press Release issued today by UK Rapid Test Consortium (“UK-RTC”) on developing a COVID-19 lateral flow antibody test (“COVID-19 Rapid Test”) that can be used by people in their homes.

As announced on 9 April 2020, the Company signed a Memorandum of Understanding (“MOU”) with Abingdon Health Limited, BBI Solutions Limited, CIGA Healthcare Limited, in conjunction with the University of Oxford to form the UK-RTC in order to jointly develop and manufacture a COVID-19 Rapid Test as part of the Government’s five pillar national testing strategy for COVID-19.

As lead partner of the UK-RTC, Abingdon Health Limited has been developing the COVID-19 Rapid Test and the Company notes the significant progress made to date in such a short period of time. The Company’s role as a member of the UK-RTC is unchanged in that it is providing development support where required and will provide volume manufacturing capacity of the COVID-19 Rapid Test once design freeze has been attained by Abingdon Health and they have successfully transferred the manufacturing protocols to the Company.

Omega will provide a further update once design freeze of the COVID-19 Rapid Test has been reached, a key milestone that the consortium hopes will be attained in June.

The UK-RTC Press Release is provided in full at the end of this announcement.

**Colin King, CEO of Omega commented:** “I am really impressed with the progress Abingdon have made to date with the development in such a short period of time. Everyone is working extremely hard to deliver a high-quality product as soon as possible to help play a part in returning life back to more normal levels in the UK. ”

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

---

**Original URL:** https://www.share-talk.com/omega-diagnostics-gp-odx-l-update-on-progress-of-uk-rapid-test-consortium/
*Created by [WP Markdown Endpoint](https://wpmarkdownendpoint.com/)*